Wordt geladen...
Towards personalised therapy for von Willebrand disease: a future role for recombinant products
von Willebrand disease (VWD) is reportedly the most common bleeding disorder and is caused by deficiencies and/or defects in the adhesive plasma protein von Willebrand factor (VWF). Functionally, normal VWF prevents bleeding by promoting both primary and secondary haemostasis. In respect to primary...
Bewaard in:
| Gepubliceerd in: | Blood Transfus |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Edizioni SIMTI - SIMTI Servizi Srl
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918558/ https://ncbi.nlm.nih.gov/pubmed/27136426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2016.0258-15 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|